Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome
Authors
Keywords
-
Journal
JAMA Cardiology
Volume 7, Issue 4, Pages 407
Publisher
American Medical Association (AMA)
Online
2022-03-03
DOI
10.1001/jamacardio.2021.5244
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Patient Selection and Clinical Outcomes in the STOPDAPT-2 Trial
- (2021) Kenji Kanenawa et al. Circulation-Cardiovascular Interventions
- Management of Antithrombotic Therapy after Acute Coronary Syndromes
- (2021) Fatima Rodriguez et al. NEW ENGLAND JOURNAL OF MEDICINE
- P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials
- (2021) Marco Valgimigli et al. BMJ-British Medical Journal
- JCS 2020 Guideline Focused Update on Antithrombotic Therapy in Patients With Coronary Artery Disease
- (2020) Masato Nakamura et al. CIRCULATION JOURNAL
- Effect of Ticagrelor Monotherapy vs Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events in Patients With Acute Coronary Syndrome
- (2020) Byeong-Keuk Kim et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
- (2020) Jean-Philippe Collet et al. EUROPEAN HEART JOURNAL
- Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS
- (2020) Usman Baber et al. EUROPEAN HEART JOURNAL
- Application of the Modified High Bleeding Risk Criteria for Japanese Patients in an All-Comers Registry of Percutaneous Coronary Intervention ― From the CREDO-Kyoto Registry Cohort-3 ―
- (2020) Masahiro Natsuaki et al. CIRCULATION JOURNAL
- Short dual antiplatelet therapy followed by P2Y12 inhibitor monotherapy vs. prolonged dual antiplatelet therapy after percutaneous coronary intervention with second-generation drug-eluting stents: a systematic review and meta-analysis of randomized clinical trials
- (2020) Daniele Giacoppo et al. EUROPEAN HEART JOURNAL
- Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention
- (2019) Philip Urban et al. CIRCULATION
- Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention
- (2019) Joo-Yong Hahn et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI
- (2019) Hirotoshi Watanabe et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Ticagrelor with or without Aspirin in High-Risk Patients after PCI
- (2019) Roxana Mehran et al. NEW ENGLAND JOURNAL OF MEDICINE
- Benefit and Risks of Aspirin in Addition to Ticagrelor in Acute Coronary Syndromes
- (2019) Mariusz Tomaniak et al. JAMA Cardiology
- Application of the Academic Research Consortium High Bleeding Risk Criteria in an All-Comers Registry of Percutaneous Coronary Intervention
- (2019) Masahiro Natsuaki et al. Circulation-Cardiovascular Interventions
- Prediction of Thrombotic and Bleeding Events After Percutaneous Coronary Intervention: CREDO‐Kyoto Thrombotic and Bleeding Risk Scores
- (2018) Masahiro Natsuaki et al. Journal of the American Heart Association
- Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
- (2018) Pascal Vranckx et al. LANCET
- 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
- (2017) Marco Valgimigli et al. EUROPEAN HEART JOURNAL
- Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents
- (2016) Usman Baber et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Biodegradable Polymer Biolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent
- (2013) Masahiro Natsuaki et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary Stenting
- (2012) Marco Valgimigli et al. CIRCULATION
- Comparison of Everolimus-Eluting and Sirolimus-Eluting Coronary Stents
- (2012) Takeshi Kimura et al. CIRCULATION
- Third Universal Definition of Myocardial Infarction
- (2012) Kristian Thygesen et al. CIRCULATION
- A New Strategy for Discontinuation of Dual Antiplatelet Therapy
- (2012) Byeong-Keuk Kim et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Randomized Trial of Stents versus Bypass Surgery for Left Main Coronary Artery Disease
- (2011) Seung-Jung Park et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
- (2009) Lars Wallentin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease
- (2009) Patrick W. Serruys et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now